Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Mirati Therapeutics (MRTX) stocks in Canada
Learn how to easily invest in Mirati Therapeutics stocks.
Mirati Therapeutics is a biotechnology business based in the US. Mirati Therapeutics stocks (MRTX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $163.51 – an increase of 1.74% over the previous week. Mirati Therapeutics employs 199 staff and has a trailing 12-month revenue of around $73.5 million.
How to buy shares in Mirati Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MRTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Mirati Therapeutics?
- Has coronavirus impacted Mirati Therapeutics shares?
- Mirati Therapeutics shares summary
- Compare share dealing platforms
- Is Mirati Therapeutics stock a buy or sell?
- Mirati Therapeutics performance over time
- Mirati Therapeutics's financials
- How volatile are Mirati Therapeutics shares?
- Does Mirati Therapeutics pay a dividend?
- Have Mirati Therapeutics shares ever split?
- Other common questions
Mirati Therapeutics stock price (NASDAQ:MRTX)Use our graph to track the performance of MRTX stocks over time.
Mirati Therapeutics shares at a glance
|Latest market close||$120.81|
|52-week range||$115.57 - $225.47|
|50-day moving average||$141.02|
|200-day moving average||$157.43|
|Wall St. target price||$220.08|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-9.54|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Mirati Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Mirati Therapeutics price performance over time
|1 week (2022-01-13)||1.74%|
|1 month (2021-12-17)||-16.66%|
|3 months (2021-10-20)||-31.47%|
|6 months (2021-07-20)||-26.13%|
|1 year (2021-01-20)||-43.23%|
|2 years (2020-01-17)||24.48%|
|3 years (2019-01-18)||86.09%|
|5 years (2017-01-20)||2,201.14%|
Mirati Therapeutics financials
|Revenue TTM||$73.5 million|
|Gross profit TTM||$13.4 million|
|Return on assets TTM||-32.19%|
|Return on equity TTM||-59.11%|
|Market capitalisation||$6.9 billion|
TTM: trailing 12 months
Mirati Therapeutics share dividends
We're not expecting Mirati Therapeutics to pay a dividend over the next 12 months.
Have Mirati Therapeutics's shares ever split?
Mirati Therapeutics's shares were split on a 1:50 basis on 2 July 2013. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Mirati Therapeutics shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Mirati Therapeutics shares which in turn could have impacted Mirati Therapeutics's share price.
Mirati Therapeutics share price volatility
Over the last 12 months, Mirati Therapeutics's shares have ranged in value from as little as $115.57 up to $225.465. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mirati Therapeutics's is 1.3259. This would suggest that Mirati Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Mirati Therapeutics overview
Mirati Therapeutics, Inc. , a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase I/II clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; and Sitravatinib, an investigational spectrum-selective kinase inhibitor that is in Phase II clinical trial for the treatment of NSCL cancer, as well as a KRAS G12D inhibitor program, which is in preclinical development. It has a collaboration and license agreement with BeiGene, Ltd. to develop, manufacture, and commercialize sitravatinib; and a clinical collaboration agreement with Novartis Pharmaceuticals Corporation. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.
Stocks similar to Mirati Therapeutics
Mirati Therapeutics in the news
Should Investors Worry About Mirati Therapeutics Inc's Insider Sells?
BridgeBio (BBIO), Amgen Partner in Advanced Solid Tumors Study
Why Mirati Therapeutics Was Sinking This Week
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.